Catalyst Information

Catalyst helps founders in healthcare and life sciences translate emerging technologies into scalable products, markets, and growth. Fractional product leadership and strategy across therapeutics, diagnostics, medical technologies, and AI-driven platforms. Strategic decisions made at a company’s inception often determine its trajectory for years. Whether building a therapeutic program, an AI algorithm, or platform technology, founders must make critical choices amid incomplete data, rapidly evolving science, and global competitive pressure. The healthcare and life sciences industry is experiencing its own “ChatGPT moment.” New biological signal detection modalities and AI-driven workflows are expanding capabilities while increasing complexity. As a result, founders increasingly face a fundamental question: how can AI meaningfully improve margins, productivity, or product capabilities rather than simply add technological complexity? Through Catalyst, I work alongside founders and CEOs to translate these signals into clear product and platform strategies. I combine primary research, competitive intelligence, and deep domain expertise to develop strategies that are analytically rigorous and executable under real-world constraints. I take a modality-agnostic approach across therapeutics, diagnostics, medical technologies, and AI-driven platforms, supporting companies throughout the pre-commercial journey—from early indication decisions to the investor conversations that fund the next phase.